Mission Wealth Management, LP Medi Wound Ltd. Transaction History

Mission Wealth Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.2 - $4.01 $29,704 - $54,143	-13,502 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$3.38 - $5.71 $3,380 - $5,710	1,000 Added 8.0%	13,502 $52,000
Q1 2021 May 10, 2021	BUY	$3.77 - $6.05 $7,540 - $12,100	2,000 Added 19.04%	12,502 $67,000
Q4 2020 Jan 19, 2021	BUY	$3.12 - $4.08 $32,766 - $42,848	10,502 New	10,502 $39,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $789M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

Stay updated on Mission Wealth Management, LP with notifications on news.